OXXYNEA® GS: Study for Glycaemia Management
Launched by FYTEXIA · Jun 29, 2023
Trial Information
Current as of June 14, 2025
Recruiting
Keywords
ClinConnect Summary
The OXXYNEA® GS study is looking to find out if certain plant-based extracts can help improve blood sugar levels in people who are overweight and at risk of diabetes. Specifically, the trial will test a combination of rich botanical extracts, white kidney bean extract, and some minerals over a period of time. Researchers will measure important blood sugar markers and gather feedback from participants to see how effective these treatments are. This study involves 87 volunteers divided into three groups, and it is designed to ensure that neither the participants nor the researchers know who is receiving which treatment.
To participate, individuals need to be between 20 and 50 years old, overweight, and have specific blood sugar levels and test results. However, people with certain health issues, women who are pregnant or breastfeeding, and those with a history of weight issues or substance abuse are not eligible. If you join the study, you can expect regular check-ins and tests to monitor your health and the effects of the treatment. The findings from this study could be important for developing new ways to manage blood sugar levels in individuals at risk of diabetes.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Fasting Plasma Glucose 75 - 125 mg/dL
- • HbA1c: 5.-6.5 %
- • Both sexes
- • Overweight BMI range (25-30 Kg/m2)
- • Age: 20-50 years old
- Exclusion Criteria:
- • Metabolic/Chronical disease
- • Menopausal women
- • Being pregnant, breastfeeding or wanting to have a baby
- • Former obese with a history of yoyo effect
- • Have been involved in a weight loss program in the past 12 months or subjected to weight reduction surgery
- • Having started or quit smoking, having a high alcohol consumption
- • Have in the past been in a long-term antibiotherapy (1 month or more) and/or a regular antibiotherapy in the past 12 months
- • Allergy to olive, blackcurrant, pomegranate, grapefruit, white kidney bean, or corn.
About Fytexia
Fytexia is a pioneering research and development company dedicated to the creation of innovative health solutions through the exploration of natural ingredients. With a strong focus on clinical trials and scientific validation, Fytexia harnesses cutting-edge methodologies to assess the efficacy and safety of its products, aimed at enhancing well-being across various health domains. The company is committed to advancing nutritional science and improving public health outcomes through rigorous research and collaboration with healthcare professionals and academic institutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Guadalupe, Murcia, Spain
Patients applied
Trial Officials
Pedro Alcaraz
Principal Investigator
UCAM (Universidad Catolica San Antonio de Murcia)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported